Orca Pharmaceuticals

Develops oral drugs for the treatment of chronic inflammatory diseases

placeAbingdon, England, United Kingdom calendar_todayFounded 2012 groups2 employees language orcapharmaceuticals.com

Registered entities

Innovation

3 patent families (1 granted) — focus: Human necessities; filing pace dormant. Cited 60 times.

YearFilings
20141
20162
20172
20181
20191
20201

Investor mix

2 investors on record; lead investors include BioMotiv.

Investor typeCountShare
Other / undisclosed2100%
Coming soon